FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023876937> ?p ?o ?g. }

• W2023876937 endingPage "e4774" @default.
• W2023876937 startingPage "e4774" @default.
• W2023876937 abstract "Cachexia is among the most debilitating and life-threatening aspects of cancer. It represents a metabolic syndrome affecting essential functional circuits involved in the regulation of homeostasis, and includes anorexia, fat and muscle tissue wasting. The anorexigenic peptide alpha-MSH is believed to be crucially involved in the normal and pathologic regulation of food intake. It was speculated that blockade of its central physiological target, the melanocortin (MC)-4 receptor, might provide a promising anti-cachexia treatment strategy. This idea is supported by the fact that in animal studies, agouti-related protein (AgRP), the endogenous inverse agonist at the MC-4 receptor, was found to affect two hallmark features of cachexia, i.e. to increase food intake and to reduce energy expenditure.SNT207707 and SNT209858 are two recently discovered, non peptidic, chemically unrelated, orally active MC-4 receptor antagonists penetrating the blood brain barrier. Both compounds were found to distinctly increase food intake in healthy mice. Moreover, in mice subcutaneously implanted with C26 adenocarcinoma cells, repeated oral administration (starting the day after tumor implantation) of each of the two compounds almost completely prevented tumor induced weight loss, and diminished loss of lean body mass and fat mass.In contrast to the previously reported peptidic and small molecule MC-4 antagonists, the compounds described here work by the oral administration route. Orally active compounds might offer a considerable advantage for the treatment of cachexia patients." @default.
• W2023876937 created "2016-06-24" @default.
• W2023876937 creator A5005257710 @default.
• W2023876937 creator A5013244689 @default.
• W2023876937 creator A5016412980 @default.
• W2023876937 creator A5017246222 @default.
• W2023876937 creator A5042822389 @default.
• W2023876937 creator A5051925049 @default.
• W2023876937 creator A5056505267 @default.
• W2023876937 creator A5068820848 @default.
• W2023876937 creator A5070656805 @default.
• W2023876937 creator A5074942166 @default.
• W2023876937 date "2009-03-19" @default.
• W2023876937 modified "2023-10-13" @default.
• W2023876937 title "Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice" @default.
• W2023876937 cites W1498791370 @default.
• W2023876937 cites W1698695320 @default.
• W2023876937 cites W1966708423 @default.
• W2023876937 cites W1972802674 @default.
• W2023876937 cites W1981215438 @default.
• W2023876937 cites W1983621897 @default.
• W2023876937 cites W1984479317 @default.
• W2023876937 cites W1990056772 @default.
• W2023876937 cites W1991717139 @default.
• W2023876937 cites W1992694261 @default.
• W2023876937 cites W1997083490 @default.
• W2023876937 cites W2000003362 @default.
• W2023876937 cites W2003064100 @default.
• W2023876937 cites W2008869575 @default.
• W2023876937 cites W2010142606 @default.
• W2023876937 cites W2021571532 @default.
• W2023876937 cites W2046517965 @default.
• W2023876937 cites W2071880152 @default.
• W2023876937 cites W2083116048 @default.
• W2023876937 cites W2088086126 @default.
• W2023876937 cites W2088873105 @default.
• W2023876937 cites W2097493897 @default.
• W2023876937 cites W2098972213 @default.
• W2023876937 cites W2124170024 @default.
• W2023876937 cites W2138166605 @default.
• W2023876937 cites W2164539030 @default.
• W2023876937 cites W2410293071 @default.
• W2023876937 doi "https://doi.org/10.1371/journal.pone.0004774" @default.
• W2023876937 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2654097" @default.
• W2023876937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19295909" @default.
• W2023876937 hasPublicationYear "2009" @default.
• W2023876937 type Work @default.
• W2023876937 sameAs 2023876937 @default.
• W2023876937 citedByCount "48" @default.
• W2023876937 countsByYear W20238769372012 @default.
• W2023876937 countsByYear W20238769372013 @default.
• W2023876937 countsByYear W20238769372014 @default.
• W2023876937 countsByYear W20238769372015 @default.
• W2023876937 countsByYear W20238769372016 @default.
• W2023876937 countsByYear W20238769372017 @default.
• W2023876937 countsByYear W20238769372018 @default.
• W2023876937 countsByYear W20238769372019 @default.
• W2023876937 countsByYear W20238769372020 @default.
• W2023876937 countsByYear W20238769372021 @default.
• W2023876937 countsByYear W20238769372022 @default.
• W2023876937 countsByYear W20238769372023 @default.
• W2023876937 crossrefType "journal-article" @default.
• W2023876937 hasAuthorship W2023876937A5005257710 @default.
• W2023876937 hasAuthorship W2023876937A5013244689 @default.
• W2023876937 hasAuthorship W2023876937A5016412980 @default.
• W2023876937 hasAuthorship W2023876937A5017246222 @default.
• W2023876937 hasAuthorship W2023876937A5042822389 @default.
• W2023876937 hasAuthorship W2023876937A5051925049 @default.
• W2023876937 hasAuthorship W2023876937A5056505267 @default.
• W2023876937 hasAuthorship W2023876937A5068820848 @default.
• W2023876937 hasAuthorship W2023876937A5070656805 @default.
• W2023876937 hasAuthorship W2023876937A5074942166 @default.
• W2023876937 hasBestOaLocation W20238769371 @default.
• W2023876937 hasConcept C120863210 @default.
• W2023876937 hasConcept C121608353 @default.
• W2023876937 hasConcept C126322002 @default.
• W2023876937 hasConcept C134018914 @default.
• W2023876937 hasConcept C147583825 @default.
• W2023876937 hasConcept C170493617 @default.
• W2023876937 hasConcept C2491326 @default.
• W2023876937 hasConcept C2777704314 @default.
• W2023876937 hasConcept C2778654693 @default.
• W2023876937 hasConcept C2778938600 @default.
• W2023876937 hasConcept C2779764123 @default.
• W2023876937 hasConcept C2779993316 @default.
• W2023876937 hasConcept C43295716 @default.
• W2023876937 hasConcept C71924100 @default.
• W2023876937 hasConcept C75908981 @default.
• W2023876937 hasConcept C89951826 @default.
• W2023876937 hasConceptScore W2023876937C120863210 @default.
• W2023876937 hasConceptScore W2023876937C121608353 @default.
• W2023876937 hasConceptScore W2023876937C126322002 @default.
• W2023876937 hasConceptScore W2023876937C134018914 @default.
• W2023876937 hasConceptScore W2023876937C147583825 @default.
• W2023876937 hasConceptScore W2023876937C170493617 @default.
• W2023876937 hasConceptScore W2023876937C2491326 @default.
• W2023876937 hasConceptScore W2023876937C2777704314 @default.
• W2023876937 hasConceptScore W2023876937C2778654693 @default.

• next